OPV as Potential Protection Against COVID-19
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- COVID
- Morbidity
- Mortality
- Non-specific Effects of Vaccines
- Poliovirus Vaccine, Oral
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Care Provider, Outcomes Assessor)Masking Description: Participants are cluster randomised to OPV or no vaccine. Information on group assignment is not available to health center staff and staff at the health and demographic surveillance systemPrimary Purpose: Prevention
Participation Requirements
- Age
- Between 50 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04445428
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Ane Fisker, MD, PhD Bandim Health Project